IRIS Accounts Production v24.3.0.553 06665938 Board of Directors 1.4.23 31.3.24 31.3.24 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh066659382023-03-31066659382024-03-31066659382023-04-012024-03-31066659382022-03-31066659382022-04-012023-03-31066659382023-03-3106665938ns15:EnglandWales2023-04-012024-03-3106665938ns14:PoundSterling2023-04-012024-03-3106665938ns10:Director12023-04-012024-03-3106665938ns10:PrivateLimitedCompanyLtd2023-04-012024-03-3106665938ns10:SmallEntities2023-04-012024-03-3106665938ns10:AuditExempt-NoAccountantsReport2023-04-012024-03-3106665938ns10:SmallCompaniesRegimeForDirectorsReport2023-04-012024-03-3106665938ns10:SmallCompaniesRegimeForAccounts2023-04-012024-03-3106665938ns10:FullAccounts2023-04-012024-03-3106665938ns10:Director22023-04-012024-03-3106665938ns10:RegisteredOffice2023-04-012024-03-3106665938ns5:CurrentFinancialInstruments2024-03-3106665938ns5:CurrentFinancialInstruments2023-03-3106665938ns5:ShareCapital2024-03-3106665938ns5:ShareCapital2023-03-3106665938ns5:RetainedEarningsAccumulatedLosses2024-03-3106665938ns5:RetainedEarningsAccumulatedLosses2023-03-3106665938ns5:PlantMachinery2023-04-012024-03-3106665938ns5:PlantMachinery2023-03-3106665938ns5:PlantMachinery2024-03-3106665938ns5:PlantMachinery2023-03-3106665938ns5:CurrentFinancialInstrumentsns5:WithinOneYear2024-03-3106665938ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3106665938ns10:Director222023-03-3106665938ns10:Director222022-03-3106665938ns10:Director222023-04-012024-03-3106665938ns10:Director222022-04-012023-03-3106665938ns10:Director222024-03-3106665938ns10:Director222023-03-31066659381ns10:Director12023-03-31066659381ns10:Director12022-03-31066659381ns10:Director12023-04-012024-03-31066659381ns10:Director12022-04-012023-03-31066659381ns10:Director12024-03-31066659381ns10:Director12023-03-31
REGISTERED NUMBER: 06665938 (England and Wales)












Unaudited Financial Statements

for the Year Ended 31 March 2024

for

Northern Fertility And Gynaecology
Services Ltd

Northern Fertility And Gynaecology
Services Ltd (Registered number: 06665938)






Contents of the Financial Statements
for the Year Ended 31 March 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


Northern Fertility And Gynaecology
Services Ltd

Company Information
for the Year Ended 31 March 2024







DIRECTORS: Mr I A Aird
Mr I O Evbuomwan





REGISTERED OFFICE: 17 Queens Lane
Newcastle upon Tyne
Tyne and Wear
NE1 1RN





REGISTERED NUMBER: 06665938 (England and Wales)





ACCOUNTANTS: Evelyn Partners
17 Queens Lane
Newcastle upon Tyne
Tyne and Wear
NE1 1RN

Northern Fertility And Gynaecology
Services Ltd (Registered number: 06665938)

Balance Sheet
31 March 2024

2024 2023
Notes £    £   
FIXED ASSETS
Tangible assets 5 2,419 4,122

CURRENT ASSETS
Debtors 6 7,502 1,364
Cash at bank 6,471 22,277
13,973 23,641
CREDITORS
Amounts falling due within one year 7 (15,190 ) (22,317 )
NET CURRENT (LIABILITIES)/ASSETS (1,217 ) 1,324
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,202

5,446

CAPITAL AND RESERVES
Called up share capital 900 900
Profit and loss account 302 4,546
SHAREHOLDERS' FUNDS 1,202 5,446

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Profit and Loss Account has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 8 November 2024 and were signed on its behalf by:





Mr I O Evbuomwan - Director


Northern Fertility And Gynaecology
Services Ltd (Registered number: 06665938)

Notes to the Financial Statements
for the Year Ended 31 March 2024

1. STATUTORY INFORMATION

Northern Fertility And Gynaecology Services Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).


2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable and represents amounts receivable for services rendered, stated net of discounts and of Value Added Tax.

The company recognises revenue when the amount of revenue can be measured reliably and when it is probable that future economic benefits will flow to the entity.

Rendering of services:
The company provides fertility and other gynaecological treatment services. When the outcome of a transaction for the provision of services can be estimated reliably in terms of revenue, costs, and its stage of completion, the company recognises revenue on the sales of services in the reporting period in which the services are rendered by reference to the stage of completion of the specific transaction at the end of the reporting period. The stage of completion is determined on the basis of the actual completion of a proportion of the total services to be rendered.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on cost

Tangible fixed assets are measured at cost less accumulated depreciation and any accumulated impairment losses.

Impairment of assets
At each reporting date fixed assets are reviewed to determine whether there is any indication that those assets have suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any affected asset is estimated and compared with its carrying amount. If estimated recoverable amount is lower, the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised immediately in profit or loss.

If an impairment loss subsequently reverses, the carrying amount of the asset is increased to the revised estimate of its recoverable amount, but not in excess of the amount that would have been determined had no impairment loss been recognised for the asset in prior years. A reversal of an impairment loss is recognised immediately in profit or loss.

Financial instruments
The company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other accounts receivable and payable, loans from banks and other third parties, loans to related parties and investments on non-puttable ordinary shares.

Financial assets that are measured at cost and amortised cost are assessed at the end of each reporting period for objective evidence of impairment. If objective evidence of impairment is found, an impairment loss is recognised in profit or loss.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Profit and Loss Account, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Northern Fertility And Gynaecology
Services Ltd (Registered number: 06665938)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

3. ACCOUNTING POLICIES - continued

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Employee benefits
Short term employee benefits are recognised as an expense in the period in which they are incurred.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1 April 2023
and 31 March 2024 16,631
DEPRECIATION
At 1 April 2023 12,509
Charge for year 1,703
At 31 March 2024 14,212
NET BOOK VALUE
At 31 March 2024 2,419
At 31 March 2023 4,122

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 5,840 1,364
Other debtors 1,662 -
7,502 1,364

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Taxation and social security 12,862 16,009
Other creditors 2,328 6,308
15,190 22,317

Northern Fertility And Gynaecology
Services Ltd (Registered number: 06665938)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2024

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 March 2024 and 31 March 2023:

2024 2023
£    £   
Mr I A Aird
Balance outstanding at start of year - -
Amounts advanced 1,265 -
Amounts repaid (750 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 515 -

Mr I O Evbuomwan
Balance outstanding at start of year - -
Amounts advanced 1,897 -
Amounts repaid (750 ) -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,147 -

The above loan is unsecured, interest free and repayable on demand.